These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 1859474)

  • 1. Effect of experimental cirrhosis on cholephilic dye metabolism and excretion in the rat.
    Lopez P; de Lamo M; Gonzalez P; Tuñon MJ; Gonzalez J
    Biochem Pharmacol; 1991 Jul; 42(3):704-7. PubMed ID: 1859474
    [No Abstract]   [Full Text] [Related]  

  • 2. The effect of portocaval shunt on bile flow and maximal biliary excretion of bromsulfophthalein sodium (BSP) in rats with thioacetamide induced liver cirrhosis.
    Bodnár A; Karácsonyi S; Zsigmond G
    Z Exp Chir; 1981 Feb; 14(1):35-9. PubMed ID: 7234017
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of cholephilic dyes on hepatic tight junctional permeability in the rat.
    Roma MG; Marinelli RA; Crocenzi FA; Rodríguez Garay EA
    Biochem Pharmacol; 1995 Sep; 50(7):1079-86. PubMed ID: 7575664
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chenodeoxycholic acid-3-sulfate. Metabolism and excretion in the rat and hamster and effects on hepatic transport systems.
    Eng C; Javitt NB
    Biochem Pharmacol; 1983 Dec; 32(23):3555-8. PubMed ID: 6651875
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Incidence of experimental cirrhosis on hepatic disposition of [3H] levamisole in rats.
    Galtier P; Coche Y; Camguilhem R
    J Pharm Pharmacol; 1982 May; 34(5):310-3. PubMed ID: 6123569
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel transcellular transport pathway for non-bile salt cholephilic organic anions.
    Aoyama N; Tokumo H; Ohya T; Chandler K; Holzbach RT
    Am J Physiol; 1991 Aug; 261(2 Pt 1):G305-11. PubMed ID: 1872399
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Determination of sulfobromophthalein excretion in rabbits.
    Quale JM; Bergasa NV; Mandel LJ
    Am J Physiol; 1988 Jun; 254(6 Pt 2):R1043-6. PubMed ID: 3269212
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A direct assessment of the importance of conjugation for biliary transport of sulfobromophthalein sodium.
    Whelan G; Hoch J; Combes B
    J Lab Clin Med; 1970 Apr; 75(4):542-57. PubMed ID: 5444343
    [No Abstract]   [Full Text] [Related]  

  • 9. Effect of 1,3-bis-(2-chloroethyl)-1-nitrosourea on cholephilic dye metabolism and excretion in anesthetized rats.
    Hoyt D; Larson RE
    J Pharmacol Exp Ther; 1989 May; 249(2):450-5. PubMed ID: 2724133
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of sulfobromophthalein (BSP) and sulfobromophthalein glutathione (BSP-GSH) disposition under conditions of altered liver function and in the isolated perfused rat liver.
    Yam J; Reeves M; Roberts RJ
    J Lab Clin Med; 1976 Mar; 87(3):373-83. PubMed ID: 1249471
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics, hepatic biotransformation and biliary and urinary excretion of bromosulfophthalein (BSP) in an experimental liver disease mimicking biliary cirrhosis.
    Esteller A; Torres MD; Gomez-Bautista M; Mariño EL; Fernandez-Lastra C; Jimenez R
    Eur J Drug Metab Pharmacokinet; 1990; 15(1):7-14. PubMed ID: 2384120
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of diethyl maleate pretreatment on biliary excretion and choleretic action of sulfobromophthalein in rats.
    Aza MJ; Gonzalez J; Esteller A
    Arch Int Pharmacodyn Ther; 1986 Jun; 281(2):321-30. PubMed ID: 3753105
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biliary cefpiramide excretion: its relation to biliary excretion of bile acids and sulfobromophthalein.
    Takikawa H; Uchida Y; Sano N; Yamanaka M
    Pharmacology; 1995 Jun; 51(1):24-32. PubMed ID: 7568341
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biliary excretion of cholephilic organic dyes in glutathione-depleted rats.
    Yoshida H; Kuronuma Y; Iijima M; Harada T
    J Hepatol; 1994 Apr; 20(4):441-5. PubMed ID: 8051379
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Injection site dependence of the appearance of sulfobromophthalein and phenolphthalein in bile.
    Hickey AJ; Shokri M; Tian Y
    Biopharm Drug Dispos; 1991 Nov; 12(8):633-6. PubMed ID: 1801968
    [No Abstract]   [Full Text] [Related]  

  • 16. Bile flow and biliary sulfobromophthalein sodium excretion in rats with liver cirrhosis and portacaval shunt.
    Zsigmond G; Bodnár A; Schaff Z; Karácsonyi S
    Eur Surg Res; 1982; 14(5):344-57. PubMed ID: 7128652
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Absorption of organic anions as model drugs following application to rat liver surface in-vivo.
    Nishida K; Sato N; Sasaki H; Nakamura J
    J Pharm Pharmacol; 1994 Nov; 46(11):867-70. PubMed ID: 7897589
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dibromosulphophthalein: its pharmacokinetics and binding to hepatic cytosol proteins in rats with acute renal failure.
    Silberstein DJ; Bowmer CJ; Yates MS
    Br J Pharmacol; 1988 Oct; 95(2):343-52. PubMed ID: 3228667
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biliary elimination of bromsulphthalein, phenolphthalein, and doxorubicin released from microspheres following intravenous administration.
    Hickey AJ; Tian Y; Parasrampuria D; Kanke M
    Biopharm Drug Dispos; 1993 Mar; 14(2):181-6. PubMed ID: 8453027
    [No Abstract]   [Full Text] [Related]  

  • 20. Increased biliary excretion of glutathione is generated by the glutathione-dependent hepatobiliary transport of antimony and bismuth.
    Gyurasics A; Koszorús L; Varga F; Gregus Z
    Biochem Pharmacol; 1992 Oct; 44(7):1275-81. PubMed ID: 1417951
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.